Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference:
Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference


Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the Wells Fargo Healthcare Conference on Thursday, Sept. 5, 2024.



Bernard Zovighian, chief executive officer

EQS-News: Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
EQS-News: Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
EQS-News: Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
EQS-News: Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
EQS-News: Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
EQS-News: Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
Premier, Inc. Reports Fiscal-Year 2024 Fourth-Quarter and Full-Year Results
Premier, Inc. Reports Fiscal-Year 2024 Fourth-Quarter and Full-Year Results


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 fourth quarter and full year ended June 30, 2024

Premier, Inc. Appoints Glenn Coleman as Chief Administrative and Financial Officer
Premier, Inc. Appoints Glenn Coleman as Chief Administrative and Financial Officer


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that Glenn Coleman, CPA, was unanimously appointed by the Board of Directors to serve as

AllSpire Health Partners Selects Premier, Inc. as its National GPO
AllSpire Health Partners Selects Premier, Inc. as its National GPO


Premier, Inc. (NASDAQ: PINC), a leading technology-enabled healthcare improvement company, today announced that it has been selected by AllSpire Health GPO, LLC (AllSpire), a regional group

LivaNova to Present at the Baird Global Healthcare Conference
LivaNova to Present at the Baird Global Healthcare Conference


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Baird 2024 Global

Inaugural Humana Community Day Promotes Health Benefits of Volunteerism
Inaugural Humana Community Day Promotes Health Benefits of Volunteerism


Several thousand green-shirted Humana employees will volunteer in Louisville on Aug. 21, marking the anniversary of the company’s founding, demonstrating Humana’s commitment to its hometown and

QuidelOrtho to Participate in Upcoming Investor Conferences: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho to Participate in Upcoming Investor Conferences


QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine

Humana Announces New Veteran Hiring Strategy and Recognition as Top Veteran-Friendly Company
Humana Announces New Veteran Hiring Strategy and Recognition as Top Veteran-Friendly Company


Humana Inc. (NYSE: HUM), a leading health and well-being company, launches a refreshed military-connected hiring strategy and earns recognition by U.S. Veterans Magazine as a Top Veteran-Friendly

Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance:
Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance


Agilent Technologies Inc., (NYSE: A) today announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatography/mass spectrometry (GC/MS) column

EQS-News: Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
EQS-News: Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
EQS-News: Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
EQS-News: Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
EQS-News: Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
EQS-News: Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
EQS-News: Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024
EQS-News: Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024
EQS-News: Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024
EQS-News: Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024
EQS-News: Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024
EQS-News: Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. Declares Quarterly Cash Dividend


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common

STAAR Surgical Reports Second Quarter 2024 Results
STAAR Surgical Reports Second Quarter 2024 Results


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

Inogen Announces Second Quarter 2024 Financial Results
Inogen Announces Second Quarter 2024 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30

EQS-News: Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area
EQS-News: Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area
EQS-News: Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area
EQS-News: Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area
EQS-News: Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area
EQS-News: Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy


Agilent Technologies Inc., (NYSE: A) today announced that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Simulations Plus Releases DILIsym® X
Simulations Plus Releases DILIsym® X


Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the

QuidelOrtho Reports Second Quarter 2024 Financial Results: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Reports Second Quarter 2024 Financial Results


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs, and